Impaired differentiation and apoptosis of hematopoietic precursors in a mouse model of myelodysplastic syndrome

Haematologica

Volumn 93, Issue 9, 2008, Pages 1394-1397

  Choi, Chul Won ^a   Chung, Yang Jo ^a   Slape, Christopher ^a   Aplan, Peter D ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

Apoptosis; HOXD13; Mouse model; Myelodysplastic syndromes; NUP98

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; FUSION GENE; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; MOUSE; MYELODYSPLASTIC SYNDROME; NHD13 GENE; NONHUMAN;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; DISEASE MODELS, ANIMAL; HEMATOPOIETIC SYSTEM; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELODYSPLASTIC SYNDROMES;

EID: 50849126819     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.13042     Document Type: Article

References (19)

1. Heaney ML, Golde DW. Myelodysplasia. N Engl J Med 1999;340:1649-60.
2. Kerbauy DB, Deeg HJ. Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome. Exp Hematol 2007;35:1739-46.
3. Gersuk GM, Beckham C, Loken MR, Kiener P, Anderson JE, Farrand A, et al. A role for tumour necrosis factor-α, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. Br J Haematol 1998;103:176-88.
4. Parker JE, Mufti GJ. The role of apoptosis in the pathogenesis of the myelodysplastic syndromes. Int J Hematol 2001;73:416-28.
5. Yoshida Y, Mufti GJ. Apoptosis and its significance in MDS: controversies revisited. Leuk Res 1999;23:777-85.
6. Corey SJ, Minden MD, Barber DL, Kantarjian H, Wang JC, Schimmer AD. Myelodysplastic syndromes: the complexity of stem-cell diseases. Nat Rev Cancer 2007;7:118-29.
7. Haak HL, Kerkhofs H, van der Linden JS, Schonewille H, van der Sanden-van der Meer HS, Hermans J. Significance of in vitro cultures in myelodysplastic syndromes. Scand J Haematol 1986;37:380-9.
8. Juvonen E, Aimolahti A, Volin L, Ruutu T. The prognostic value of in vitro cultures of erythroid and megakaryocyte progenitors in myelodysplastic syndromes. Leuk Res 1999;23:889-94.
9. Ruutu T, Partanen S, Lintula R, Teerenhovi L, Knuutila S. Erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes. Scand J Haematol 1984;32:395-402.
10. Slape C, Aplan PD. The role of NUP98 gene fusions in hematologic malignancy. Leuk Lymphoma 2004;45:1341-50.
11. Lin YW, Slape C, Zhang Z, Aplan PD. NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia. Blood 2005;106:287-95.
12. Martinez-Jaramillo G, Flores-Figueroa E, Sanchez-Valle E, Gutierrez-Espindola G, Gomez-Morales E, Montesinos JJ, et al. Comparative analysis of the in vitro proliferation and expansion of hematopoietic progenitors from patients with aplastic anemia and myelodysplasia. Leuk Res 2002;26:955-63.
13. + cells. Leuk Lymphoma 1994;14:37-47.
14. Claessens YE, Bouscary D, Dupont JM, Picard F, Melle J, Gisselbrecht S, et al. In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis. Blood 2002;99:1594-601.
15. Span LF, Rutten E, Gemmink A, Boezeman JB, Raymakers RA, de Witte T. Bone marrow mononuclear cells of MDS patients are characterized by in vitro proliferation and increased apoptosis independently of stromal interactions. Leuk Res 2007;31:1659-67.
16. Span LF, Vierwinden G, Pennings AH, Boezeman JB, Raymakers RA, de Witte T. Programmed cell death is an intrinsic feature of MDS progenitors, predominantly found in the cluster-forming cells. Exp Hematol 2005;33:435-42.
17. Amanullah A, Liebermann DA, Hoffman B. p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation. Oncogene 2000;19:2967-77.
18. Slape C, Chung YJ, Soloway PD, Tessarollo L, Aplan PD. Mouse embryonic stem cells that express a NUP98-HOXD13 fusion protein are impaired in their ability to differentiate and can be complemented by BCR-ABL. Leukemia 2007;21:1239-48.
19. Drexler HG. Malignant hematopoietic cell lines: in vitro models for the study of myelodysplastic syndromes. Leuk Res 2000;24:109-15.